IP Library › Granted Patent US 11,359,221
Granted Patent B2
US 11,359,221 · App. 16/981,595 · Granted Jun 14, 2022

Efficient product cleavage in template-free enzymatic synthesis of polynucleotides

Inventor: Sandrine Creton (Le Kremlin-Bicêtre, FR)
Assignee: DNA Script SAS
C12P19/14C12P19/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,359,221
App. No.
16/981,595
Granted
Jun 14, 2022
Kind
B2
Abstract

The present invention is directed to methods and kits for template-free enzymatic synthesis of polynucleotides that include or enable a step of efficiently cleaving the polynucleotide products from its initiator using endonuclease V activity and initiator with a 3′-penultimate deoxyinosine.

Claims (16)

1. A method of synthesizing a polynucleotide having a predetermined sequence, the method comprising the steps of:

a) providing an initiator having a 3′-penultimate deoxyinosine and a 3′-terminal nucleotide having a free 3′-hydroxyl;

b) repeating cycles of

(i) contacting under elongation conditions the initiator or elongated fragments having free 3′-O-hydroxyls with a 3′-O-blocked nucleoside triphosphate and a terminal deoxynucleotidyl transferase so that the initiator or elongated fragments of the initiator are elongated by incorporation of a 3′-O-blocked nucleoside triphosphate to form 3′-O-blocked elongated fragments, and

(ii) deblocking the elongated fragments to form elongated fragments having free 3′-hydroxyls,

 until the polynucleotide having the predetermined sequence is formed; and

c) treating the polynucleotide with an endonuclease V activity to cleave the polynucleotide from the initiator, such that the polynucleotide cleaved from the initiator has a 5′-monophosphate.

2. The method of claim 1 , wherein said endonuclease V activity is provided by a prokaryotic endonuclease V.

3. The method of claim 2 , wherein said prokaryotic endonuclease V is an E. coli endonuclease V.

4. The method of claim 2 , further comprising a step of removing said prokaryotic endonuclease V from said cleaved polynucleotide.

5. The method of claim 1 , wherein said initiator is attached to a support by a 5′ end.

6. The method of claim 5 , wherein said support is a solid support.

7. The method of claim 1 , wherein said initiator has a 3′-terminal sequence of 5′-dI-dT-3′.

8. The method of claim 1 , wherein said blocking group attached to said 3′-oxygen is azidomethyl.

9. The method of claim 1 , wherein said blocking group attached to said 3′-oxygen is amino.

10. The method of claim 1 , wherein said blocking group attached to said 3′-oxygen is allyl.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2020
From: CRETON, SANDRINE
To: DNA SCRIPT SAS
Reel/Frame 054197/0481 →
Priority Claims (1)
EP 19305174 · Feb 12, 2019 · regional
Continuity (1)
Related Publication 20210254114A1 · Aug 19, 2021
Cited By (1)
US 12,703,860